- Home
- SNY vs COP Comparison
SNY vs COP Comparison
Compare SNY & COP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- COP
- Stock Information
- Founded
- SNY 1994
- COP 1917
- Country
- SNY France
- COP United States
- Employees
- SNY N/A
- COP N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- COP Integrated oil Companies
- Sector
- SNY Health Care
- COP Energy
- Exchange
- SNY Nasdaq
- COP Nasdaq
- Market Cap
- SNY 127.2B
- COP 116.9B
- IPO Year
- SNY N/A
- COP N/A
- Fundamental
- Price
- SNY $49.37
- COP $85.30
- Analyst Decision
- SNY Buy
- COP Buy
- Analyst Count
- SNY 2
- COP 17
- Target Price
- SNY $62.50
- COP $119.31
- AVG Volume (30 Days)
- SNY 2.4M
- COP 8.6M
- Earning Date
- SNY 07-24-2025
- COP 05-08-2025
- Dividend Yield
- SNY 4.48%
- COP 3.66%
- EPS Growth
- SNY 39.56
- COP N/A
- EPS
- SNY 5.45
- COP 7.91
- Revenue
- SNY $48,817,552,946.00
- COP $59,090,000,000.00
- Revenue This Year
- SNY $3.39
- COP $7.84
- Revenue Next Year
- SNY $7.05
- COP $1.84
- P/E Ratio
- SNY $17.77
- COP $10.79
- Revenue Growth
- SNY N/A
- COP 4.00
- 52 Week Low
- SNY $45.80
- COP $79.88
- 52 Week High
- SNY $60.12
- COP $118.40
- Technical
- Relative Strength Index (RSI)
- SNY 38.24
- COP 39.43
- Support Level
- SNY $51.80
- COP $84.28
- Resistance Level
- SNY $52.41
- COP $86.61
- Average True Range (ATR)
- SNY 0.83
- COP 1.82
- MACD
- SNY -0.06
- COP -0.46
- Stochastic Oscillator
- SNY 16.44
- COP 9.40
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. In 2024, it produced 2.0 million barrels per day of oil and natural gas liquids and 3.4 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2024 were 7.8 billion barrels of oil equivalent.